Apontis Pharma AG engages in the marketing and sale of medical drugs for indication fields of internal medicine in Germany. It offers single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prophylaxis, as well as respiratory diseases and diabetes. The company was founded in 1946 and is based in Monheim am Rhein, Germany. As of November 21, 2024, Apontis Pharma AG operates as a subsidiary of Zentiva AG.
Show more...
FAQ
Apontis Pharma 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 Boerse Muenchen 交易所,Apontis Pharma 的股票以代號 APPH.MU 進行交易。
Apontis Pharma 去年的營收是多少?▼
Apontis Pharma 去年的營收為 48.47MEUR。
Apontis Pharma 去年的淨利是多少?▼
APPH.MU 去年的淨收益為 754,000EUR。
Apontis Pharma 有多少名員工?▼
截至 August 25, 2026,公司共有 137 名員工。
Apontis Pharma 位於哪個產業?▼
Apontis Pharma從事於Health & Wellness產業。
Apontis Pharma 何時完成拆股?▼
Apontis Pharma 最近沒有進行任何拆股。
Apontis Pharma 的總部在哪裡?▼
Apontis Pharma 的總部位於 德國 的 Monheim am Rhein。